|
AGFG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.415080E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.417200E-03 |
| Normal-vs-Stage2 |
1.98060999999639E-05 |
| Normal-vs-Stage3 |
1.666080E-02 |
| Normal-vs-Stage4 |
9.037900E-03 |
| Stage1-vs-Stage2 |
1.876100E-02 |
| Stage1-vs-Stage3 |
6.143400E-01 |
| Stage1-vs-Stage4 |
9.993000E-01 |
| Stage2-vs-Stage3 |
2.347800E-02 |
| Stage2-vs-Stage4 |
5.099900E-02 |
| Stage3-vs-Stage4 |
7.133400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.482000E-03 |
| Normal-vs-AfricanAmerican |
4.280000E-01 |
| Normal-vs-Asian |
9.041700E-03 |
| Caucasian-vs-AfricanAmerican |
2.651200E-01 |
| Caucasian-vs-Asian |
6.361400E-01 |
| AfricanAmerican-vs-Asian |
1.948210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.753300E-04 |
| Normal-vs-Female |
3.138100E-03 |
| Male-vs-Female |
3.489200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.087840E-02 |
| Normal-vs-Age(41-60Yrs) |
2.613400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.541600E-03 |
| Normal-vs-Age(81-100Yrs) |
7.987800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.150240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.199000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.193600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.684600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.588240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.028400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.221700E-02 |
| Classical-VS-Follicular |
9.70519997700592E-09 |
| Classical-VS-Other |
1.122030E-01 |
| Classical-VS-Normal |
3.093700E-02 |
| Tall-VS-Follicular |
2.01310000003119E-06 |
| Tall-VS-Other |
4.195600E-02 |
| Tall-VS-Normal |
8.884800E-01 |
| Follicular-VS-Other |
7.623600E-01 |
| Follicular-VS-Normal |
1.15299999547958E-08 |
| Other-VS-Normal |
1.450420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18269999996412E-06 |
| Normal-vs-N1 |
6.618300E-03 |
| N0-vs-N1 |
2.064000E-01 |
|
|
